SART3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-1893
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-MSNADFAKLFLRK corresponding to C-Terminus according to NP_055521.1.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for SART3 Antibody
Western Blot: SART3 Antibody [NB100-1893]
Western Blot: SART3 Antibody [NB100-1893] - (1ug/ml) analysis of Daudi lysate (RIPA buffer, 30ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.Applications for SART3 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:16000
Western Blot
0.01 - 0.03 ug/ml
Application Notes
WB: Approx. 170 kDa band observed in Daudi, Jurkat and MOLT4 lysates is reported in scientific literature (PMID: 10463607).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SART3
Alternate Names
DSAP1, hSART-3, KIAA0156squamous cell carcinoma antigen recognised by T cells 3, P100, p110, p110(nrb), RP11-13G14, SART-3, squamous cell carcinoma antigen recognized by T cells 3, squamous cell carcinoma antigen recognized by T-cells 3, Tat-interacting protein of 110 kDa, Tip110, TIP110MGC138188
Entrez Gene IDs
9733 (Human)
Gene Symbol
SART3
UniProt
Additional SART3 Products
Product Documents for SART3 Antibody
Product Specific Notices for SART3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...